Mir-21 is over-expressed (among other microRNAs) in primary CD34+ cells of TKI-resistant patients [36] and in the blastic phase of the disease [25]; it might participate in the TKI-dependent apoptosis of the CD34+ CML cells [27]. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.